Ledger.Open graph →
SEC Form D · filed February 25, 2022

Reset Pharmaceuticals, Inc

Offering
$12.7M
Sold
$11.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Tim Schlidt · New York, NYDirectorJohn Andreadis · New York, NYExec · DirectorJan-Anders Karlsson · LONDON, United KingdomExec · DirectorPhilip Taub · New York, NYDirectorJohn Andreadis · New York, NYExec · DirectorJan-Anders Karlsson · LONDON, United KingdomExec · DirectorPhilip Taub · New York, NYDirectorTim Schlidt · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗